Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 876 — Gastroenterology-Urology Devices · § 876.5982

§ 876.5982. Ingested, transient, space occupying device for weight management and/or weight loss.

238 words·~1 min read·/us/cfr/t21/s§ 876.5982·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. This device is an ingested material that transiently occupies space in the stomach. The device passes from the body via the natural gastrointestinal tract.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)The patient-contacting components of the device must be demonstrated to be biocompatible for its intended use.
(2)Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions for use, as follows:
(i)Performance bench testing in a simulated use model must evaluate device disintegration and device hydration state throughout the gastrointestinal tract;
(ii)Bioburden and moisture content assessments must evaluate device infection risk throughout the labeled shelf life; and
(iii)Performance data must support the shelf life of the device by demonstrating continued package integrity and device functionality over the labeled shelf life.
(3)Clinical performance testing must demonstrate the device performs as intended and evaluate the following:
(i)Weight change;
(ii)All adverse events, including obstruction, dilation, diarrhea, constipation, and dehydration; and
(iii)Interaction with representative medications.
(4)Physician and patient device labeling must state:
(i)The clinical benefit of the device as assessed by using percent total body weight loss;
(ii)Treatment must be offered in combination with diet and exercise;
(iii)Instructions on how to use the device as intended including how to avoid interaction with medication; and
(iv)The shelf life of the device. [86 FR 70372, Dec. 10, 2021]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 876.5982
Ingested, transient, space occupying device for weight management and/or weight loss.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.